293 related articles for article (PubMed ID: 23340112)
1. The holistic integration of virtual screening in drug discovery.
Tanrikulu Y; Krüger B; Proschak E
Drug Discov Today; 2013 Apr; 18(7-8):358-64. PubMed ID: 23340112
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in fragment-based lead discovery.
Schulz MN; Hubbard RE
Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
[TBL] [Abstract][Full Text] [Related]
5. How far can virtual screening take us in drug discovery?
Kar S; Roy K
Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
[TBL] [Abstract][Full Text] [Related]
6. Docking and Virtual Screening in Drug Discovery.
Kontoyianni M
Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
[TBL] [Abstract][Full Text] [Related]
7. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
8. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
9. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
10. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
11. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
Drewry DH; Macarron R
Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
[TBL] [Abstract][Full Text] [Related]
12. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
Hevener KE
Methods Mol Biol; 2018; 1800():275-285. PubMed ID: 29934898
[TBL] [Abstract][Full Text] [Related]
13. Concise review: a high-content screening approach to stem cell research and drug discovery.
Xia X; Wong ST
Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
[TBL] [Abstract][Full Text] [Related]
14. Recent trends and observations in the design of high-quality screening collections.
Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
Gul S; Hadian K
Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
[TBL] [Abstract][Full Text] [Related]
16. A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA).
Alagappan M; Jiang D; Denko N; Koong AC
Adv Exp Med Biol; 2016; 899():253-68. PubMed ID: 27325272
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening strategies: recent advances in the identification and design of anti-cancer agents.
Kumar V; Krishna S; Siddiqi MI
Methods; 2015 Jan; 71():64-70. PubMed ID: 25171960
[TBL] [Abstract][Full Text] [Related]
18. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
19. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
20. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]